Loading the state's markets…
Loading the state's markets…
Loading the market…
Medicare market size, surgeons and outlook to 2030
Medicare fee-for-service SI joint fusion cases in North Carolina: reported (2020, the pandemic year, left out of the line), then forecast with its 80% range. One year ahead, this procedure’s market forecast has been off by 16% on average (37 state-years, 2020–2024): small markets swing, so treat it as rough.
| Year | Surgeons | Medicare FFS | Advantage share |
|---|---|---|---|
| 2019 | 1 | 112 | 40% |
| 2020 | 2 | 131 | 43% |
| 2021 | 1 | 116 | 48% |
| 2022 | 0 | 81 | 52% |
| 2023 | 2 | 197 | 56% |
| 2024 | 3 | 167 | 59% |
| 2025 from claims | – | 224 181–263 | 61% |
| 2026 forecast | – | 244 191–307 | 62% |
| 2027 forecast | – | 266 197–351 | 62% |
| 2028 forecast | – | 289 204–398 | 63% |
| 2029 forecast | – | 314 213–450 | 64% |
| 2030 forecast | – | 341 223–505 | 65% |
Minimally invasive and open sacroiliac joint fusion. Professional codes (what the surgeon bills): CPT 27279, 27280, 0775T, 27278.
Surgeons and fee-for-service cases are from CMS’s Medicare Physician & Other Practitioners files, counted where the surgeon billed; state totals include the cases CMS leaves out of the surgeon-level file (under 11 patients). All Medicare adds patients in Medicare Advantage at the state’s enrollment share; all payers scales Medicare by its share of the procedure nationally. The forecast carries cases per resident 65+ forward with the Census projection of residents 65+. How the numbers are made · Data sources
The 10 busiest do 100% of the cases CMS names in North Carolina; 3 surgeons do 80% of them.
MedaRep names every one, ranked by volume, with their practice, hospitals, trend, forecast and which device companies already engage with them.
In 2025, 39% inpatient hospital, 48% hospital outpatient, 13% surgery center.
CMS rule changes ahead
From CMS’s OPPS/ASC final rules; the move measured on CMS’s claim summary, nationally, code by code. Medicare only, and not in the projected bars.
| State | Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast |
|---|---|---|---|---|---|---|
| Texas | 20 | 1,201+17%/yr | +17%/yr | 0.5 | 59% | 2,330 in 2030+12%/yr |
| Florida | 18 | 1,158+12%/yr | +12%/yr | 0.5 | 66% | 2,840 in 2030+16%/yr |
| Oklahoma | 9 | 370+24%/yr | +24%/yr | 0.7 | 54% | 610 in 2030+8.7%/yr |
| Georgia | 7 | 300+10%/yr | +10%/yr | 0.3 | 67% | 370 in 2030+3.5%/yr |
| South Carolina | 3 | 206+39%/yr | +39%/yr | 0.3 | 14% | 340 in 2030+8.7%/yr |
| Tennessee | 3 | 175+24%/yr | +24%/yr | 0.2 | 16% | 320 in 2030+11%/yr |
| Virginia | 3 | 167+8.3%/yr | +8.3%/yr | 0.1 | 0% | 390 in 2030+15%/yr |
| Maryland | 2 | 164+22%/yr | +22%/yr | 0.2 | 0% | 290 in 2030+10%/yr |
| Louisiana | 1 | 124+13%/yr | +13%/yr | 0.3 | 0% | 350 in 2030+19%/yr |
| Alabama | 1 | 100+11%/yr | +11%/yr | 0.2 | 0% | 60 in 2030−8.8%/yr |
| Kentucky | 2 | 100−6.4%/yr | −6.4%/yr | 0.2 | 0% | 170 in 2030+8.9%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Decompression & minimally invasive spine | 90 | 3,162−8.5%/yr | −8.5%/yr | 3.10.9× | 17% | 3,120 in 2030−0.2%/yr |
| Lumbar fusion | 81 | 3,107−4.5%/yr | −4.5%/yr | 3.00.9× | 0% | 3,140 in 2030+0.2%/yr |
| Cervical fusion & disc arthroplasty | 26 | 1,686−6.3%/yr | −6.3%/yr | 1.61.0× | 6% | 1,550 in 2030−1.4%/yr |
| Kyphoplasty & vertebroplasty | 16 | 1,376−9.2%/yr | −9.2%/yr | 1.40.8× | 27% | 1,380 in 20300%/yr |
SI joint fusion in every state, and its device makers · Every procedure market in North Carolina · Every state · Compare with Texas
SI-BONE leads with 68% of company spending on these surgeons in 2025, −25 pts on 2024.
In 2025, 7 companies reported engagement with North Carolina’s surgeons worth $91K in consulting, speaking, meals and travel tied to these products, about $30K per surgeon billing it. Royalties are left out.
FDA, last 12 months: 7 clearances and approvals in the category, 1 recalled product line. A recall is a public FDA notice, not a finding of fault.
Which surgeons each company engages, and the dollars reported, are in the ranking. Open Payments shows the payments companies reported. It suggests engagement, not which devices a surgeon uses, and is not evidence of wrongdoing. Every company in the category.
Share of the cases CMS names by surgeon, by where they billed. Open one for its ranking.
For CPT 27279 (arthrd si jt perq/min nvas), commercial plans pay North Carolina’s hospitals a median of $17K, from $17K at the lowest to $21K at the highest, across 8 hospitals that publish a price.
Each hospital’s median over its commercial plans, from the machine-readable files hospitals must post; not every hospital is loaded.